Kingdon Capital Management, L.L.C. Rapt Therapeutics, Inc. Transaction History

Kingdon Capital Management, L.L.C.

$834 Million
Q3 2024

A detailed history of Kingdon Capital Management, L.L.C. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 1,725,000 shares of RAPT stock, worth $2 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

1,725,000

Previous 1,725,000 -0.0%

Holding current value

$2 Million

Previous $5.26 Million 34.1%

% of portfolio

0.42%

Previous 0.61%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.89 - $9.38 $650,250 - $2.11 Million	225,000 Added 15.0%	1,725,000 $5.26 Million
Q1 2024 May 15, 2024	BUY	$6.87 - $26.45 $3.67 Million - $14.1 Million	534,172 Added 55.31%	1,500,000 $13.5 Million
Q4 2023 Feb 14, 2024	BUY	$11.28 - $25.46 $1.8 Million - $4.07 Million	160,000 Added 19.86%	965,828 $24 Million
Q3 2023 Nov 14, 2023	SELL	$16.34 - $24.66 $3.17 Million - $4.79 Million	-194,172 Reduced 19.42%	805,828 $13.4 Million
Q2 2023 Aug 14, 2023	BUY	$16.06 - $21.61 $1.99 Million - $2.68 Million	124,016 Added 14.16%	1,000,000 $18.7 Million
Q1 2023 May 15, 2023	SELL	$17.19 - $30.8 $69,035 - $123,692	-4,016 Reduced 0.46%	875,984 $16.1 Million
Q4 2022 Feb 14, 2023	BUY	$16.28 - $24.6 $3.33 Million - $5.03 Million	204,383 Added 30.25%	880,000 $17.4 Million
Q3 2022 Nov 14, 2022	SELL	$17.96 - $30.46 $6.24 Million - $10.6 Million	-347,704 Reduced 33.98%	675,617 $16.3 Million
Q2 2022 Aug 15, 2022	SELL	$10.26 - $23.59 $666,900 - $1.53 Million	-65,000 Reduced 5.97%	1,023,321 $18.7 Million
Q1 2022 May 16, 2022	SELL	$17.02 - $40.22 $1.02 Million - $2.41 Million	-60,000 Reduced 5.23%	1,088,321 $23.9 Million
Q3 2021 Nov 15, 2021	BUY	$29.86 - $39.47 $11.3 Million - $14.9 Million	377,500 Added 48.97%	1,148,321 $35.7 Million
Q2 2021 Aug 16, 2021	BUY	$17.99 - $40.02 $9.84 Million - $21.9 Million	546,800 Added 244.08%	770,821 $24.5 Million
Q1 2021 May 17, 2021	SELL	$16.0 - $24.46 $473,392 - $723,698	-29,587 Reduced 11.67%	224,021 $4.97 Million
Q4 2020 Feb 16, 2021	BUY	$15.89 - $40.87 $4.03 Million - $10.4 Million	253,608 New	253,608 $5.01 Million

Others Institutions Holding RAPT

# of Institutions

104

Shares Held

27.1M

Call Options Held

26.7K

Put Options Held

2.4K

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $34.4M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.

Account

Kingdon Capital Management, L.L.C. Rapt Therapeutics, Inc. Transaction History